anonymous
Guest
anonymous
Guest
More failure in the form of Coherus drug that was rejected by FDA due to GMP violations at the KBI site.
How did management react?
More failure in the form of Coherus drug that was rejected by FDA due to GMP violations at the KBI site.
Management was not happy obviously, but recognize there is only so much they can do with an inept workforce...they need better support from those on the floorHow did management react?
Management was not happy obviously, but recognize there is only so much they can do with an inept workforce...they need better support from those on the floor
More failure in the form of Coherus drug that was rejected by FDA due to GMP violations at the KBI site.
More failure in the form of Coherus drug that was rejected by FDA due to GMP violations at the KBI site.
More failure in the form of Coherus drug that was rejected by FDA due to GMP violations at the KBI site.
If this is true, which I don't know, when will it be made public?
More failure in the form of Coherus drug that was rejected by FDA due to GMP violations at the KBI site.
you all are bunch of idiots, the CRL was due to issues with the submission and had nothing to do with the FDA inspection. KBI got the pre-approval even with a list of 483s. Coherus is refiling and their competitor is behind them now too because they also got a CRL from the FDA. Talk about fake news, this is ridiculous.
you all are bunch of idiots, the CRL was due to issues with the submission and had nothing to do with the FDA inspection. KBI got the pre-approval even with a list of 483s. Coherus is refiling and their competitor is behind them now too because they also got a CRL from the FDA. Talk about fake news, this is ridiculous.
Any pharma company with an inspection with more than 1 or 2 483s should be ashamed of itself! There are federal regulations designed to protect consumers and if you have many 483s you are a danger to consumers and should be shut down! There can be no argument!
obviously some one uneducated in regulatory inspections trying to stir the pot, 483's with multiple findings are common across the industry...the number of findings is not the concern, but rather the severity of the findings...go back to cleaning the toilets and stop trying to cause problems...
The Texas site is new and I do not know about NC. Boulder is a disaster. They push to get too much accomplished in not enough time. The turnover rate is 95%+. All the good experienced workers left for other pharmas. You just cannot cut corners with biologics.Was it like that in Rocky Mt NC and Austin TX ?
Was it like that in Rocky Mt NC and Austin TX ?